AStretch welcome the recommendation within the NICE guidance that people with Axial Spondyloarthritis should be referred to a specialist physiotherapist for structured individualised exercise. 
NICE Guidance on Spondyloarthritis now published for more information visit our Collections page  



National Institute for Health and Care Excellence (NICE) has recommended certolizumab pegol (Cimzia) and secukinumab (Cosentyx) as treatment options for active psoriatic arthritis not adequately responding to DMARDs.

Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs. National Institute for Health and Care Excellence. 2017 May 24.

NASS Members' Day June 17th 2017: We were greeted with an open friendly atmosphere at this meeting in Sheffield, the delegates eager to learn and share views.  

AStretch were represented by Claire Harris and Sue Gurden who took part in one to one interviews with members. Together with Clare Clark, Sue also led the afternoon session which covered all aspects of flare symptoms and management. The Audience were engaged and very forthcoming during the interactive discussions and  also experienced a relaxing mindfulness session led by Clare.

For more information of the day and access to the photo gallery visit:…/new-friends--new-ideas-at-members-day…/

Melanie Martin reports from Rheumatology 2017:

Day 1 of BSR 2017 presented a focus on Spondyloarthritis, with a series of presentations on new      pharmacological opportunities with IL17/23 pathways, the role of imaging in diagnosing Axial SpA and an update from BritSpA on research projects underway, including dose-tapering. The highlight for me was joining this years Spondyloarthritis poster tour. The importance of smoking cessation was really highlighted and emphasises the importance on physiotherapists to promote healthy lifestyle


For your nearest NASS group follow the link

© Copyright 2017 ASTRETCHWeb Design By Toolkit Websites